Diskussion zur BICO Group Aktie WKN: A2PX00 ISIN: SE0013647385 Forum: Aktien User: Hedgehog3

Immerhin war der Auftragseingang 10% am steigen. Die Nachfrage wird also wieder größer.

Ohje Zurückhaltung bei deren Kunden, das wird auch bei BICO ein Brett

Waren leicht unter den Erwartungen,aber halten an ihrer Jahresprognose fest

Sartorius hat wohl keine guten Zahlen, ist bei 11 Prozent Minus

Anders Fogelberg appointed as Chief Commercial Officer for BICO Group AB (publ) BICO Group AB today announces the appointment of Anders Fogelberg as Chief Commercial Officer (CCO). Commercial excellence has been defined as one of the top strategic priorities for BICO and this position is pivotal in setting and driving the strategy towards that target, i.e., in scaling the BICO business, increasing the commercialization efforts of the portfolio and further explore opportunities for collaborations and partnerships. Anders Fogelberg has **** years’ experience of working with marketing and sales & business development in global organizations. He has extensive experience from different leadership positions **** as a Managing Director for the SKF Group in Malaysia and Indonesia respectively. Before joining BICO, Anders has worked in the Med Tech industry now latest as Chief Marketing Officer and Head of Sales for Profundus and before that as CEO for Bellman & Symfon. “Anders extensive global industry experience with a strong track record of commercial success including turnarounds and pharma collaborations will be a great addition to our team on our journey of improving the commercial excellence.” says Maria Forss, CEO and President BICO Group AB. “I’m excited to join the BICO team and work with an organization that has produced so many innovative life science solutions and contribute to the continuing transformation and growth of the company.” says Anders Fogelberg, assuming CCO, BICO Group AB. Anders Fogelberg will assume his new position on June 13, 2024. The CCO role is newly established, will be a member of the Executive Management and report to BICO’s CEO and President. The CCO will be main responsible for the commercial activities within the BICO Group and ensure cooperation between subsidiaries and that long-term partnerships are built with relevant partners throughout the global life science industry. BICO’s Executive Management has transformed significantly since the beginning of 2023 with appointments of new CEO, CFO, COO, and CHRO (Chief Human Resources Officer). This has formed a new leadership at BICO. For further information, please contact: Maria Forss, President & CEO, BICO Group AB Phone: EA Isabella Lundin +46 73 515 99 64 E-mail: mf@bico.com The information was submitted for publication, through the agency of the contact person set out above, on April 18, 2024 at 07.00am CEST.

Wenn wir schon bei unqualifizierten Beiträgen sind.

Oder 29,50 € 😄

2,95€ 🤔 kommt an dem Tag der Q-zahlen 😜 😅…. ☝🏻Gut zum nachlegen 😉

Dann warte mal auf deine 2.95€, am Ende rennst du hinterher und kaufst für 5€ 😅

Ein kauf drängt sich erst bei 2,95€ auf. Mutige können da eine 1. Tranche setzen

Eher etwas "administratives" - Entlastung Vorstand und Aufsichtsrat usw. Keine neuen Zahlen, die Jahreszahlen sind bereits veröffentlicht, der Q1-Report kommt am 07.05. raus - also in genau drei Wochen...

Kommen da die zahlen raus oder eher was negatives?

Einladung Mitglieder Versammlung

https://bico.com/single-press-release/?id=9dd7fd77-2db4-4ed4-97d9-07f77d0c78f9

Am Donnerstag morgen veröffentlicht Sartorius seine Q1-Zahlen. Ein spannender Indikator wie es um die Absatzmärkte/Kundensegmente von BICO derzeit steht... 🙏🏻